BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Jan 08, 2009
 |  BC Extra  |  Clinical News

Peplin reports actinic keratosis data

Peplin (ASX:PLI) said four of six PEP005 topical ingenol mebutate gel treatment groups met the primary efficacy endpoint...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >